Tarsier Pharma Ltd. (TARX) Form 10-K Annual Reports
Tarsier Pharma Ltd. (TARX) is a publicly traded company, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: TARX
CIK: 2102720
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: L3
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Somekh Chaikin
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerEhud Lev
Audit LocationTel Aviv, Israel
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| F-1/A | 2026-07-16 | — | REGISTRATION STATEMENT | 0001213900-26-078792 | View SEC Doc Filr Page |
| F-1/A | 2026-07-15 | — | REGISTRATION STATEMENT | 0001213900-26-078039 | View SEC Doc Filr Page |
| F-1/A | 2026-06-16 | — | REGISTRATION STATEMENT | 0001213900-26-069143 | View SEC Doc Filr Page |
| F-1/A | 2026-06-08 | — | REGISTRATION STATEMENT | 0001213900-26-066188 | View SEC Doc Filr Page |
| FWP | 2026-05-18 | — | FREE WRITING PROSPECTUS | 0001213900-26-058483 | View SEC Doc Filr Page |
| F-1/A | 2026-05-18 | — | REGISTRATION STATEMENT | 0001213900-26-058235 | View SEC Doc Filr Page |
| F-1 | 2026-04-21 | — | REGISTRATION STATEMENT | 0001213900-26-046063 | View SEC Doc Filr Page |
| DRS/A | 2026-03-31 | — | DRS/A Filing | 0001213900-26-036943 | View SEC Doc Filr Page |
| DRS/A | 2026-02-24 | — | DRS/A Filing | 0001213900-26-019853 | View SEC Doc Filr Page |
| DRS | 2025-12-29 | — | DRS Filing | 0001213900-25-125843 | View SEC Doc Filr Page |